$6.65
0.15% day before yesterday
Nasdaq, Jun 28, 10:02 pm CET
ISIN
US89455T1097
Symbol
TMCI

Treace Medical Concepts Inc Target price 2024 - Analyst rating & recommendation

Treace Medical Concepts Inc Classifications & Recommendation:

Hold
100%

Treace Medical Concepts Inc Target price

Target price $6.83
Course $6.65
Price potential
Number of estimates 6
6 Analysts have issued a price target Treace Medical Concepts Inc 2025 . The average Treace Medical Concepts Inc target price is $6.83. This is higher than the current share price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 0 Analysts recommend Treace Medical Concepts Inc to buy, 7 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the Treace Medical Concepts Inc share has an average upside potential 2025 of . Most analysts recommend the Treace Medical Concepts Inc share at Hold.

Sales and margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million $ 187.12 205.40
31.92% 9.77%
EBITDA margin -24.63% -6.91%
15.70% 71.94%
Net margin -26.81% -27.13%
20.26% 1.20%

7 Analysts have issued a sales forecast Treace Medical Concepts Inc 2024 . The average Treace Medical Concepts Inc sales estimate is

$205m
unlock
. This is
4.78% higher
unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
$208m 5.85%
unlock
, the lowest is
$204m 4.10%
unlock
.

This results in the following potential growth figures:

Sales forecast

2023 $187m 31.92%
2024
$205m 9.77%
unlock
2025
$230m 11.87%
unlock
2026
$256m 11.53%
unlock
2027
$311m 21.34%
unlock
2028
$358m 15.02%
unlock

6 Analysts have issued an Treace Medical Concepts Inc EBITDA forecast 2024. The average Treace Medical Concepts Inc EBITDA estimate is

$-14.2m
unlock
. This is
71.40% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-10.1m 79.75%
unlock
, the lowest is
$-17.9m 63.95%
unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 $-46.1m 52.63%
2024
$-14.2m 69.18%
unlock
2025
$-6.5m 54.47%
unlock
2026
$-592k 90.85%
unlock
2027
$15.1m 2,651.97%
unlock
2028
$33.7m 123.18%
unlock

EBITDA margin

2023 -24.63% 15.70%
2024
-6.91% 71.94%
unlock
2025
-2.81% 59.33%
unlock
2026
-0.23% 91.81%
unlock
2027
4.86% 2,213.04%
unlock
2028
9.42% 93.83%
unlock

5 Treace Medical Concepts Inc Analysts have issued a net profit forecast 2024. The average Treace Medical Concepts Inc net profit estimate is

$-55.7m
unlock
. This is
1.09% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-50.8m 7.87%
unlock
, the lowest is
$-59.4m 7.68%
unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 $-50.2m 5.19%
2024
$-55.7m 11.08%
unlock
2025
$-53.3m 4.43%
unlock
2026
$-48.7m 8.56%
unlock
2027
$-29.1m 40.21%
unlock
2028
$-15.5m 46.82%
unlock

Net margin

2023 -26.81% 20.26%
2024
-27.13% 1.20%
unlock
2025
-23.17% 14.60%
unlock
2026
-19.00% 18.00%
unlock
2027
-9.36% 50.74%
unlock
2028
-4.33% 53.74%
unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share $ -0.81 -0.90
5.19% 11.11%
P/E ratio negative
EV/Sales 1.81

5 Analysts have issued a Treace Medical Concepts Inc forecast for earnings per share. The average Treace Medical Concepts Inc <a href=/blog/eps>EPS is

$-0.90
unlock
. This is
1.12% lower
unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
$-0.82 7.87%
unlock
, the lowest is
$-0.96 7.87%
unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 $-0.81 5.19%
2024
$-0.90 11.11%
unlock
2025
$-0.86 4.44%
unlock
2026
$-0.79 8.14%
unlock
2027
$-0.47 40.51%
unlock
2028
$-0.25 46.81%
unlock

P/E ratio

Current -7.48 69.75%
2024
-7.39 1.20%
unlock
2025
-7.73 4.60%
unlock
2026
-8.46 9.44%
unlock
2027
-14.15 67.26%
unlock
2028
-26.60 87.99%
unlock

Based on analysts' sales estimates for 2024, the Treace Medical Concepts Inc share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 1.90 79.92%
2024
1.81 4.56%
unlock
2025
1.62 10.62%
unlock
2026
1.45 10.34%
unlock
2027
1.20 17.59%
unlock
2028
1.04 13.06%
unlock

P/S ratio

Current 2.10 79.19%
2024
2.01 4.56%
unlock
2025
1.79 10.62%
unlock
2026
1.61 10.34%
unlock
2027
1.33 17.59%
unlock
2028
1.15 13.06%
unlock

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now